Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells

By              

International Journal of Oncology, Vol. 47, Iss. 6, 2015-01 ,pp. : 2153-2164

Spandidos Publications

Access to resources Recommend Favorite

p53 and p21 Expression in Precancerous Lesions and Carcinomas of the Uterine Cervix: Overexpression of p53 Predicts Poor Disease Outcome

By Huang L.-W.   Chou Y.-Y.   Chao S.-L.   Chen T.-J.   Lee T.T.Y.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 348-354

Elsevier

Access to resources Recommend Favorite

Enhanced Apoptosis Correlates with Poor Survival in Patients with Laryngeal Cancer but not with Cell Proliferation, bcl-2 or p53 Expression

By Hirvikoski P.   Kumpulainen E.   Virtaniemi J.   Pirinen R.   Salmi L.   Halonen P.   Johansson R.   Kosma V.-M.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 231-237

Elsevier

Access to resources Recommend Favorite

Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy

By Kim Hee  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 777-788

Springer Publishing Company

Access to resources Recommend Favorite

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

By Boominathan Lakshmanane  

Cancer and Metastasis Reviews, Vol. 29, Iss. 4, 2010-12 ,pp. : 613-639

Springer Publishing Company

Access to resources Recommend Favorite